Published in Biochem J on September 01, 1971
Utilization of energy-providing substrates in the isolated working rat heart. Biochem J (1980) 2.94
The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. Biochem J (1975) 2.46
The effects of increased heart work on the tricarboxylate cycle and its interactions with glycolysis in the perfused rat heart. Biochem J (1972) 2.36
Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J (2003) 2.02
The regulation of the oxidation of fatty acids and other substrates in rat heart mitochondria by changes in the matrix volume induced by osmotic strength, valinomycin and Ca2+. Biochem J (1987) 1.77
Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. J Clin Invest (1988) 1.58
Metabolic compartmentation and substrate channelling in muscle cells. Role of coupled creatine kinases in in vivo regulation of cellular respiration--a synthesis. Mol Cell Biochem (1995) 1.49
The role of calcium in the ischemic myocardium. Am J Pathol (1981) 1.41
Effects of nutritional status and acute variation in substrate supply on cardiac and skeletal-muscle fructose 2,6-bisphosphate concentrations. Biochem J (1988) 1.29
Metabolic fate of extracted glucose in normal human myocardium. J Clin Invest (1985) 1.26
Analysis of rat heart in vivo by phosphorus nuclear magnetic resonance. Proc Natl Acad Sci U S A (1980) 1.20
The role of glucose in the survival and 'recovery' of the anoxic isolated perfused rat heart. Biochem J (1972) 1.20
Systematic variations in the content of the purine nucleotides in the steady-state perfused rat heart. Evidence for the existence of controlled storage and release of adenine nucleotides. Biochem J (1978) 1.14
Measurement of changes in high-energy phosphates in the cardiac cycle using gated 31P nuclear magnetic renonance. Proc Natl Acad Sci U S A (1980) 1.08
The effect of pressure or flow stress on right ventricular protein synthesis in the face of constant and restricted coronary perfusion. J Clin Invest (1975) 1.02
Alterations of myocardial amino acid metabolism in chronic ischemic heart disease. J Clin Invest (1976) 0.98
Respiratory control and substrate effects in the working rat heart. Biochem J (1992) 0.96
Protein synthesis by perfused hearts from normal and insulin-deficient rats. Effect of insulin in the presence of glucose and after depletion of glucose, glucose 6-phosphate and glycogen. Biochem J (1973) 0.94
The effects of ammonium, inorganic phosphate and potassium ions on the activity of phosphofructokinases from muscle and nervous tissues of vertebrates and invertebrates. Biochem J (1975) 0.93
Evidence for improved myocardial oxygen delivery and function during hypoxia in the mole rat. J Comp Physiol B (1988) 0.92
Some factors affecting phosphate transport in a perfused rat heart preparation. Biochem J (1980) 0.89
Characterizations of myosin essential light chain's N-terminal truncation mutant Δ43 in transgenic mouse papillary muscles by using tension transients in response to sinusoidal length alterations. J Muscle Res Cell Motil (2013) 0.89
The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart. J Clin Invest (1978) 0.89
Phosphorylation of cMyBP-C affects contractile mechanisms in a site-specific manner. Biophys J (2014) 0.87
Diversity and similarity of motor function and cross-bridge kinetics in papillary muscles of transgenic mice carrying myosin regulatory light chain mutations D166V and R58Q. J Mol Cell Cardiol (2013) 0.86
Adequacy of oxygenation of isolated perfused rat heart. Basic Res Cardiol (1984) 0.84
A study of tropomyosin's role in cardiac function and disease using thin-filament reconstituted myocardium. J Muscle Res Cell Motil (2013) 0.83
The effects of calcium ions on the activities of trehalase, hexokinase, phosphofructokinase, fructose diphosphatase and pyruvate kinase from various muscles. Biochem J (1973) 0.83
Myocardial energy production and consumption remain balanced during positive inotropic stimulation when coronary flow is restricted to basal rates in rabbit heart. J Clin Invest (1987) 0.81
DCM-related tropomyosin mutants E40K/E54K over-inhibit the actomyosin interaction and lead to a decrease in the number of cycling cross-bridges. PLoS One (2012) 0.80
Use of the perfused rat heart to study cardiac metabolism: retrospective and prospective views. Basic Res Cardiol (1984) 0.80
Independent mechanisms for the chronotropic and inotropic responses in hyperthyroidism. Basic Res Cardiol (1987) 0.78
Analysis of the molecular pathogenesis of cardiomyopathy-causing cTnT mutants I79N, ΔE96, and ΔK210. Biophys J (2013) 0.78
Ultrastructural correlates of ischaemic contracture during global subtotal ischaemia in the rat heart. J Exp Pathol (Oxford) (1990) 0.77
ATP binding and cross-bridge detachment steps during full Ca²⁺ activation: comparison of myofibril and muscle fibre mechanics by sinusoidal analysis. J Physiol (2012) 0.76
Abnormal phosphocreatine metabolism in perfused diabetic hearts. A 31P nuclear-magnetic-resonance study. Biochem J (1983) 0.76
Using baculovirus/insect cell expressed recombinant actin to study the molecular pathogenesis of HCM caused by actin mutation A331P. J Mol Cell Cardiol (2014) 0.75
Ionic regulation of sea urchin sperm motility, metabolism and fertilizing capacity. J Physiol (1986) 0.75
New concepts regarding events that lead to myocardial infarction. Cardiovasc Drugs Ther (1995) 0.75
Integration of flux measurements to resolve changes in anabolic and catabolic metabolism in cardiac myocytes. Biochem J (2017) 0.75
An improved method for the colorimetric determination of phosphate. Biochem J (1938) 95.98
The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J (1967) 12.40
Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood. Biochem J (1962) 12.21
[A simple technic for extremely rapid freezing of large pieces of tissue]. Pflugers Arch Gesamte Physiol Menschen Tiere (1960) 10.08
THE CROONIAN LECTURE, 1963. GLUCONEOGENESIS. Proc R Soc Lond B Biol Sci (1964) 5.47
Regulation of glucose uptake in muscle. I. The effects of insulin and anoxia on glucose transport and phosphorylation in the isolated, perfused heart of normal rats. J Biol Chem (1961) 5.31
Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol (1967) 4.61
Acetoacetate as fuel of respiration in the perfused rat heart. Biochem J (1961) 4.56
The activities of fructose 1,6-diphosphatase, phosphofructokinase and phosphoenolpyruvate carboxykinase in white muscle and red muscle. Biochem J (1967) 3.14
GLYCOLYTIC CONTROL MECHANISMS. I. INHIBITION OF GLYCOLYSIS BY ACETATE AND PYRUVATE IN THE ISOLATED, PERFUSED RAT HEART. J Biol Chem (1965) 2.75
Determination of citrate with citrate lyase. Anal Biochem (1966) 2.68
The action of insulin on the penetration of sugars into the perfused heart. J Physiol (1956) 2.47
Effects of insulin on the pattern of glucose metabolism in the perfused working and Langendorff heart of normal and insulin-deficient rats. Biochem J (1969) 2.46
REGULATION OF PHOSPHOFRUCTOKINASE ACTIVITY BY CITRATE IN NORMAL AND DIABETIC MUSCLE. Biochem Biophys Res Commun (1963) 2.36
Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet (1968) 1.94
Concentrations of glycerides and phospholipids in rat heart and gastrocnemius muscles. Effects of alloxan-diabetes and perfusion. Biochem J (1967) 1.78
Regulation of glucose uptake in muscle. II. Rate-limiting steps and effects of insulin and anoxia in heart muscle from diabetic rats. J Biol Chem (1961) 1.64
Metabolism of the heart in health and disease. I. Am Heart J (1968) 1.58
Functional compartmentation of ATP and creatine phosphate in heart muscle. J Mol Cell Cardiol (1970) 1.57
Citrate as a metabolic regulator in muscle and adipose tissue. Biochem Soc Symp (1968) 1.30
THE REGULATION OF HEXOKINASE AND PHOSPHOFRUCTOKINASE ACTIVITY IN HEART MUSCLE. EFFECTS OF ALLOXAN DIABETES, GROWTH HORMONE, CORTISOL, AND ANOXIA. J Biol Chem (1964) 1.28
Effects of insulin and diet on the metabolism of L-lactate and glucose by the perfused rat heart. Biochem J (1962) 1.25
Effect of pressure development on membrane transport of glucose in isolated rat heart. Am J Physiol (1967) 1.20
The control of rat-heart phosphofructokinase by citrate and other regulators. Biochem J (1966) 1.19
Utilization of endogenous lipid by the isolated perfused rat heart. Biochem J (1967) 1.11
Effect of pressure development on glucose and palmitate metabolism in perfused heart. Am J Physiol (1969) 1.11
Metabolism of glucose-U-C14 in perfused rat heart. Am J Physiol (1962) 1.08
The value of lactate and pyruvate measurements in the assessment of the redox state of free nicotinamide-adenine dinucleotide in the cytoplasm of perfused rat heart. Eur J Clin Invest (1971) 1.07
The effects of insulin, adrenaline and nutrients on the oxygen uptake of the perfused rat heart. J Physiol (1961) 1.00
Myocardial oxygen consumption of blood-perfused, isolated, supported, rat heart. Am J Physiol (1970) 0.95
Hemodynamic changes in hypophysectomized rats. Circ Res (1959) 0.91
Glucose-free fatty acid interactions in the working heart. J Appl Physiol (1970) 0.84
ADJUSTMENT OF GLYCOLYSIS TO ENERGY UTILIZATION IN THE PERFUSED RAT HEART. THE EFFECT OF CHANGES IN THE IONIC COMPOSITION OF THE MEDIUM ON PHOSPHOFRUCTOKINASE ACTIVITY. J Biol Chem (1964) 0.84
[Studies on the conditions for the oxygen supply of the myocardium in perfused rat hearts. I. On the problem following the presence of a countercurrent supply]. Pflugers Arch Gesamte Physiol Menschen Tiere (1967) 0.80
Divergence of the in vitro and in vivo extracellular space measurements in heart muscle. Experientia (1970) 0.80
Molecular switches--the ON and OFF of bacterial phase variation. Mol Microbiol (1999) 3.69
The activities of fructose 1,6-diphosphatase, phosphofructokinase and phosphoenolpyruvate carboxykinase in white muscle and red muscle. Biochem J (1967) 3.14
Beta-blockers for hypertension. Cochrane Database Syst Rev (2007) 2.91
Clinical practice and medical research: bridging the divide between the two cultures. Br J Gen Pract (1995) 2.90
Effects of insulin on the pattern of glucose metabolism in the perfused working and Langendorff heart of normal and insulin-deficient rats. Biochem J (1969) 2.46
South African hypertension guideline 2006. S Afr Med J (2006) 2.23
Sudden death and sport. Lancet (1975) 2.14
Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet (1994) 1.99
Drugs and the heart. III. Calcium antagonists. Lancet (1980) 1.99
Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides. Biochem J (1994) 1.94
Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet (1968) 1.94
Housing and health: does installing heating in their homes improve the health of children with asthma? Public Health (2000) 1.85
Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone. Am J Cardiol (1986) 1.75
Chlamydia: One step forward or two backwards? BMJ (1988) 1.75
Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet (1983) 1.69
Antigenic and enzymatic architecture of Micrococcus lysodeikticus membranes established by crossed immunoelectrophoresis. Proc Natl Acad Sci U S A (1975) 1.68
The major phase-variable outer membrane protein of Escherichia coli structurally resembles the immunoglobulin A1 protease class of exported protein and is regulated by a novel mechanism involving Dam and oxyR. J Bacteriol (1999) 1.65
Glucose-insulin-potassium (GIK) for acute myocardial infarction: a negative study with a positive value. Cardiovasc Drugs Ther (1999) 1.63
Nifedipine and mortality. Grave defects in the dossier. Circulation (1995) 1.61
Molecular structure of membrane vesicles from Escherichia coli. Proc Natl Acad Sci U S A (1978) 1.60
Adverse interaction between nifedipine and beta-blockade. Br Med J (1980) 1.60
Metabolism of the heart in health and disease. I. Am Heart J (1968) 1.58
Immunochemical analysis of inner and outer membranes of Escherichia coli by crossed immunoelectrophoresis. J Bacteriol (1978) 1.57
Recognising meningococcal disease in primary care: qualitative study of how general practitioners process clinical and contextual information. BMJ (1998) 1.54
Antigen 43, a phase-variable bipartite outer membrane protein, determines colony morphology and autoaggregation in Escherichia coli K-12. FEMS Microbiol Lett (1997) 1.52
Recognizing meningococcal disease: the case for further research in primary care. Br J Gen Pract (1998) 1.51
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
The diagnostic accuracy of cervico-vaginal fetal fibronectin in predicting preterm delivery: an overview. Br J Obstet Gynaecol (1997) 1.45
Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review. Q J Med (1984) 1.43
Increased plasma-free-fatty-acid concentrations and their significance in patients with acute myocardial infarction. Lancet (1969) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Antigenic architecture of membrane vesicles from Escherichia coli. Biochemistry (1979) 1.40
Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon. Circulation (1975) 1.39
Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol (1991) 1.39
Effect of oxygenation and consequent pH changes on the efficacy of St. Thomas' Hospital cardioplegic solution. J Thorac Cardiovasc Surg (1991) 1.39
Some dilemmas in managing gynaecological infections. Br J Gen Pract (1996) 1.38
Myocardial blood flow, deoxyglucose uptake, and myocyte viability in ischemia. J Nucl Med (1992) 1.38
Immunochemical analysis of membrane vesicles from Escherichia coli. Biochemistry (1979) 1.31
Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol. Am Heart J (1982) 1.28
Characterization of the "border zone" in acute regional ischemia in the dog. Am J Cardiol (1977) 1.28
Multiple forms of staphylococcal alpha-toxin. J Med Microbiol (1972) 1.28
Isolation and properties of mesosomal membrane fractions from Micrococcus lysodeikticus. Biochem J (1972) 1.26
Influence of anti-insulin serum on glucose metabolism. II. In the perfused heart. Diabetes (1967) 1.25
Bacterial membrane structure. Annu Rev Microbiol (1976) 1.25
Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. Am J Cardiol (1975) 1.25
Drugs and the heart. VI. Vasodilating drugs. Lancet (1980) 1.23
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
Drugs and the heart. Lancet (1980) 1.21
Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV. Infect Immun (1986) 1.20
Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ Res (1996) 1.19
Biochemical aspects of arrhythmogenesis and ventricular fibrillation. Am J Cardiol (1979) 1.18
Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res (1992) 1.18
Metabolic response during impending myocardial infarction. I. Relevance of studies of glucose and fatty acid metabolism in animals. Circulation (1972) 1.18
Coronary flow rate and perfusion pressure as determinants of mechanical function and oxidative metabolism of isolated perfused rat heart. J Physiol (1965) 1.16
Effects of substrates on tissue metabolic changes in the isolated rat heart during underperfusion and on release of lactate dehydrogenase and arrhythmias during reperfusion. Circ Res (1978) 1.16
Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart. Am J Cardiol (1979) 1.13
Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Circ Res (1990) 1.13
The effect of insulin and insulin deficiency on the transport and metabolism of glucose by rat small intestine. J Physiol (1971) 1.13
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis (1989) 1.13
The succinate dehydrogenase of Escherichia coli. Immunochemical resolution and biophysical characterization of a 4-subunit enzyme complex. J Biol Chem (1985) 1.12
Metabolism of triglyceride fatty acid by the perfused rat heart. Biochem J (1967) 1.12
Pyruvate metabolism in the perfused rat heart. Am J Physiol (1963) 1.11
Adenosine cardioplegia. Adenosine versus potassium cardioplegia: effects on cardiac arrest and postischemic recovery in the isolated rat heart. J Thorac Cardiovasc Surg (1989) 1.09
Relative changes in free-fatty-acid and glucose utilisation by ischaemic myocardium after coronary-artery occlusion. Lancet (1969) 1.08
Effects of free fatty acid and enzyme release in experimental glucose on myocardial infarction. Nature (1975) 1.07
Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res (2000) 1.07
The value of lactate and pyruvate measurements in the assessment of the redox state of free nicotinamide-adenine dinucleotide in the cytoplasm of perfused rat heart. Eur J Clin Invest (1971) 1.07
Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res (1990) 1.07
Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte. Mol Cell Biochem (1998) 1.07
Cyclic AMP levels in ischaemic and non-ischaemic myocardium following coronary artery ligation: relation to ventricular fibrillation. J Mol Cell Cardiol (1978) 1.06
Calcium channel blockers and preconditioning. J Mol Cell Cardiol (2000) 1.06
Antigen 43, the major phase-variable protein of the Escherichia coli outer membrane, can exist as a family of proteins encoded by multiple alleles. Microbiology (2001) 1.06
The inhibition of skeletal-muscle fructose 1,6-diphosphatase by adenosine monophosphate. Biochem J (1967) 1.06
Drugs and the heart four years on. Lancet (1984) 1.05
Purification and N-terminal sequence of the alpha subunit of antigen 43, a unique protein complex associated with the outer membrane of Escherichia coli. J Bacteriol (1989) 1.04
Identification and partial characterization of a novel bipartite protein antigen associated with the outer membrane of Escherichia coli. J Bacteriol (1987) 1.04
Ventricular arrhythmias associated with coronary artery occlusion and reperfusion in the isolated perfused rat heart: a model for assessment of antifibrillatory action of antiarrhythmic agents. Cardiovasc Res (1978) 1.04
Immunochemical and biochemical analysis of the polyvalent Pseudomonas aeruginosa vaccine PEV. Infect Immun (1986) 1.04
Experimental myocardial infarction with left ventricular failure in the isolated perfused rat heart. Effects of isoproterenol and pacing. J Mol Cell Cardiol (1975) 1.04
Adolescent medicine. BMJ (1992) 1.03
Effect of fatty acids on contractility and rhythm of the heart. Nature (1970) 1.03
Role of cyclic nucleotides in heart metabolism. Cardiovasc Res (1982) 1.02
A relationship between adenosine triphosphate, glycolysis and ischaemic contracture in the isolated rat heart. J Mol Cell Cardiol (1981) 1.02
A succinylated mannan in the membrane system of Micrococcus lysodeikticus. Biochem Biophys Res Commun (1975) 1.01
Chemical synthesis, purification, and folding of C-X-C and C-C chemokines. Methods Enzymol (1997) 1.01
Drugs and the heart. IV. Antiarrhythmic agents. Lancet (1980) 1.01
In-house referral: changing general practitioners' roles in the referral of patients to secondary care. Soc Sci Med (1998) 1.00
The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology (Oxford) (2005) 1.00